journal article·2025-09-19

Smartphone-Colorimetric Biosensor for Uric Acid through Morphological Transition of Silver Nanoplates

Liangchong Yu, Xiaobing Gao, Xiaoya Liu, Xiaohan Li, Zhenhua Gu, Taolei Sun, Guanbin Gao

ACS Applied Nano Materials· Volume 8· Issue 37
Publisher page

Abstract

Elevated uric acid (UA) serves as a critical biomarker for hyperuricemia-related disorders, yet conventional detection faces cost and complexity limitations. Here, we developed an enzyme-free smartphone-colorimetric biosensor using silver triangular nanoplates (AgTNPs). These anisotropic nanostructures exhibit morphology-dependent surface plasmon resonance (SPR), enabling UA-selective etching that induces a blue-to-yellow color shift. Spectrophotometry revealed a linear response (40–110 μM, R 2 > 0.992) correlating with blue shifts. Smartphone-based green-channel analysis achieved comparable accuracy (R 2 = 0.98) in a 96-well plate. Transmission electron microscopy confirmed UA-driven morphological evolution from triangular to spherical nanoparticles via anisotropic etching. This dual-mode platform provides a cost-effective solution for point-of-care UA monitoring.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Gout, Hyperuricemia, Uric Acid · Inflammasome and immune disorders · Streptococcal Infections and Treatments

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

State Key Laboratory of Advanced Technology for Materials Synthesis and Processing

Wuhan University of Technology

Hubei Key Laboratory of Nanomedicine for Neurodegenerative Diseases, School of Chemistry, Chemical Engineering and Life Science

General Hospital of Central Theater Command

Funding

National Ten Thousand Talent Program · National Natural Science Foundation of China · Youth Top Talent Project of Hubei Provence of China

References (27)

Show source-provided references
1. 10.1038/nature0451610.1038/nature04516 ↗
2. 10.1056/NEJMra080088510.1056/NEJMra0800885 ↗
3. 10.1097/01.ASN.0000034910.58454.FD10.1097/01.ASN.0000034910.58454.FD ↗
4. 10.1016/j.ecoenv.2023.11452510.1016/j.ecoenv.2023.114525 ↗
5. 10.1016/j.pharmthera.2024.10861510.1016/j.pharmthera.2024.108615 ↗
6. 10.1093/clinchem/26.2.22710.1093/clinchem/26.2.227 ↗
7. 10.1016/j.talanta.2003.10.05110.1016/j.talanta.2003.10.051 ↗
8. 10.1021/acs.analchem.6b0458810.1021/acs.analchem.6b04588 ↗
9. 10.1007/s40820-020-00536-910.1007/s40820-020-00536-9 ↗
10. 10.1007/s42114-021-00391-110.1007/s42114-021-00391-1 ↗
11. 10.1002/sstr.20240003410.1002/sstr.202400034 ↗
12. 10.1021/acsami.1c1797410.1021/acsami.1c17974 ↗
13. 10.1021/acsanm.3c0225810.1021/acsanm.3c02258 ↗
14. 10.1039/C4NR03309D10.1039/C4NR03309D ↗
15. 10.1002/idm2.1206910.1002/idm2.12069 ↗
16. 10.1021/acs.langmuir.7b0136210.1021/acs.langmuir.7b01362 ↗
17. 10.1021/ac303591n10.1021/ac303591n ↗
18. 10.1021/acsami.1c1702810.1021/acsami.1c17028 ↗
19. 10.1016/j.saa.2023.12356210.1016/j.saa.2023.123562 ↗
20. 10.1016/j.snb.2019.12704510.1016/j.snb.2019.127045 ↗
21. 10.1134/S106193482460541310.1134/S1061934824605413 ↗
22. 10.1016/j.molliq.2020.11323810.1016/j.molliq.2020.113238 ↗
23. 10.1016/j.snb.2021.13030410.1016/j.snb.2021.130304 ↗
24. 10.3390/s2203084310.3390/s22030843 ↗
25. 10.1016/j.talanta.2016.08.00810.1016/j.talanta.2016.08.008 ↗
26. 10.1116/1.124777710.1116/1.1247777 ↗
27. 10.1088/0031-8949/2/1-2/01410.1088/0031-8949/2/1-2/014 ↗